KRN330

BIOLOGICAL2 trials

Sponsors

Kyowa Kirin, Inc., Kyowa Kirin Co., Ltd.

Conditions

Colorectal Cancer

Phase 1

Phase I Study of KRN330 Monoclonal Antibody in Patients With Colorectal Cancer

CompletedNCT00575562

Kyowa Kirin, Inc.Colorectal Cancer

Start: 2007-06-30End: 2010-01-31Updated: 2024-04-29

Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer

TerminatedNCT00838578

Kyowa Kirin Co., Ltd.Colorectal Cancer

Start: 2009-03-31End: 2012-10-31Updated: 2024-04-26